Who is sponsoring REBECCA?

REBECCA is sponsored by Centre Oscar Lambret.

What condition does REBECCA study?

REBECCA studies Metastatic Colorectal Cancer.

What is the status of REBECCA?

REBECCA is currently COMPLETED.

Last reviewed 2026-03-12 · How we verify

REBECCA: A Cohort Study of Regorafenib in the Real-life Setting in Patients Previously Treated for Metastatic Colorectal Cancer.

NCT02310477 COMPLETED

This is a largest cohort study aimed to estimate the overall survival of patients been treated with regorafenib for metastatic colorectal cancer (mCRC) within the frame of a french compassionate program.

Details

Lead sponsor	Centre Oscar Lambret
Status	COMPLETED
Enrolment	704
Start date	2014-02
Completion	2014-12

Conditions

Metastatic Colorectal Cancer

Interventions

regorafenib

Primary outcomes

Overall survival (OS) — at death or at the end of study
median time between the date of the first administration REG and the date of the death

Countries

France